nodes	percent_of_prediction	percent_of_DWPC	metapath
Difluprednate—NR3C1—urine—schizophrenia	0.0803	0.294	CbGeAlD
Difluprednate—Fluocinolone Acetonide—PLA2G4A—schizophrenia	0.0718	0.353	CrCbGaD
Difluprednate—Fluticasone Propionate—PLA2G4A—schizophrenia	0.0491	0.241	CrCbGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR6—schizophrenia	0.0442	0.0845	CbGpPWpGaD
Difluprednate—NR3C1—blood plasma—schizophrenia	0.0419	0.153	CbGeAlD
Difluprednate—NR3C1—Nuclear Receptors—NR4A2—schizophrenia	0.0324	0.0619	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—NOS1AP—schizophrenia	0.0283	0.054	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—NR4A2—schizophrenia	0.0256	0.0489	CbGpPWpGaD
Difluprednate—NR3C1—forebrain—schizophrenia	0.0229	0.084	CbGeAlD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—schizophrenia	0.0227	0.0433	CbGpPWpGaD
Difluprednate—Clobetasol propionate—CYP1A2—schizophrenia	0.0225	0.11	CrCbGaD
Difluprednate—NR3C1—telencephalon—schizophrenia	0.0211	0.0772	CbGeAlD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SMARCA2—schizophrenia	0.0211	0.0403	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CLOCK—schizophrenia	0.0195	0.0372	CbGpPWpGaD
Difluprednate—NR3C1—gonad—schizophrenia	0.0176	0.0645	CbGeAlD
Difluprednate—NR3C1—AP-1 transcription factor network—NTS—schizophrenia	0.0169	0.0323	CbGpPWpGaD
Difluprednate—NR3C1—blood—schizophrenia	0.0153	0.0562	CbGeAlD
Difluprednate—NR3C1—midbrain—schizophrenia	0.0152	0.0555	CbGeAlD
Difluprednate—Megestrol acetate—ABCB1—schizophrenia	0.0151	0.0741	CrCbGaD
Difluprednate—Fluticasone furoate—ABCB1—schizophrenia	0.0145	0.0711	CrCbGaD
Difluprednate—NR3C1—Circadian Clock—CLOCK—schizophrenia	0.0142	0.0271	CbGpPWpGaD
Difluprednate—NR3C1—endocrine gland—schizophrenia	0.0133	0.0487	CbGeAlD
Difluprednate—NR3C1—nervous system—schizophrenia	0.0125	0.0456	CbGeAlD
Difluprednate—NR3C1—central nervous system—schizophrenia	0.012	0.0439	CbGeAlD
Difluprednate—NR3C1—cerebellum—schizophrenia	0.0117	0.0429	CbGeAlD
Difluprednate—Methylprednisolone—ABCB1—schizophrenia	0.0115	0.0567	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HTR3A—schizophrenia	0.0105	0.02	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CYP26B1—schizophrenia	0.0103	0.0197	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—schizophrenia	0.01	0.0192	CbGpPWpGaD
Difluprednate—NR3C1—brain—schizophrenia	0.00952	0.0348	CbGeAlD
Difluprednate—NR3C1—AP-1 transcription factor network—TH—schizophrenia	0.00813	0.0155	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR1—schizophrenia	0.00809	0.0155	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—schizophrenia	0.00809	0.0155	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—schizophrenia	0.008	0.0153	CbGpPWpGaD
Difluprednate—Betamethasone—ABCB1—schizophrenia	0.00797	0.0392	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TPH1—schizophrenia	0.00793	0.0151	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CHRNA7—schizophrenia	0.00793	0.0151	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—MEF2C—schizophrenia	0.00745	0.0142	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—schizophrenia	0.00745	0.0142	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—PRL—schizophrenia	0.00664	0.0127	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GRIN1—schizophrenia	0.00659	0.0126	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP2D6—schizophrenia	0.00649	0.0319	CrCbGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR1—schizophrenia	0.00639	0.0122	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL10—schizophrenia	0.00632	0.0121	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GAPDH—schizophrenia	0.00622	0.0119	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TNF—schizophrenia	0.00607	0.0116	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TPH2—schizophrenia	0.00601	0.0115	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.00569	0.0109	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—GSK3B—schizophrenia	0.00562	0.0107	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—schizophrenia	0.00562	0.0107	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—schizophrenia	0.00547	0.0105	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.00516	0.00987	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.00497	0.0095	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—ESR1—schizophrenia	0.00496	0.00949	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—schizophrenia	0.00493	0.00943	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.0048	0.00918	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.0048	0.00918	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.00467	0.00893	CbGpPWpGaD
Difluprednate—Dexamethasone—ABCB1—schizophrenia	0.00464	0.0228	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—FOS—schizophrenia	0.00447	0.00855	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NR4A2—schizophrenia	0.00442	0.00844	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—schizophrenia	0.00442	0.00844	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TH—schizophrenia	0.00428	0.00818	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—schizophrenia	0.00398	0.00761	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—schizophrenia	0.00397	0.00758	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—FOS—schizophrenia	0.00394	0.00753	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—MEF2C—schizophrenia	0.00375	0.00716	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—TSNAX—schizophrenia	0.0037	0.00708	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—EP300—schizophrenia	0.0037	0.00707	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.00361	0.00691	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—EP300—schizophrenia	0.00359	0.00687	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.00349	0.00666	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL10—schizophrenia	0.00333	0.00636	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.00324	0.00619	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.00313	0.00598	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—LSM1—schizophrenia	0.00302	0.00577	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—EP300—schizophrenia	0.00296	0.00566	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.00295	0.00563	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—schizophrenia	0.00264	0.00504	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—EP300—schizophrenia	0.00261	0.00499	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—schizophrenia	0.0026	0.00496	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NOTCH4—schizophrenia	0.00226	0.00432	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NR4A2—schizophrenia	0.00213	0.00407	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TP53—schizophrenia	0.00212	0.00405	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SMG6—schizophrenia	0.00195	0.00372	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—TP53—schizophrenia	0.00187	0.00357	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.00175	0.00334	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—schizophrenia	0.00159	0.00304	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—schizophrenia	0.00158	0.00301	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—EP300—schizophrenia	0.00156	0.00298	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TNF—schizophrenia	0.00147	0.0028	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TNF—schizophrenia	0.00127	0.00242	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR1—schizophrenia	0.0011	0.00211	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NOTCH4—schizophrenia	0.00109	0.00208	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—DNMT1—schizophrenia	0.000977	0.00187	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HSPA8—schizophrenia	0.000963	0.00184	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HSPA1A—schizophrenia	0.000877	0.00168	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—YWHAZ—schizophrenia	0.000636	0.00122	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR1—schizophrenia	0.000532	0.00102	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AKT1—schizophrenia	0.000192	0.000367	CbGpPWpGaD
